RETRACTION: miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A (Retraction of Vol 464, Pg 1309, 2015)

被引：0
|
作者：
Shao, Mingchen [1 ,2 ]
Geng, Yiwei [1 ,2 ]
Lu, Peng [3 ]
Xi, Ying [1 ,2 ]
Wei, Sidong [4 ]
Wang, Liuxing [1 ,2 ]
Fan, Qingxia [1 ,2 ]
Ma, Wang [1 ,2 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Oncol Dept, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Lab Tumor Biol, Zhengzhou, Henan, Peoples R China
[3] Peoples Hosp Zhengzhou, Gastrointestinal Surg Dept, Zhengzhou, Henan, Peoples R China
[4] Peoples Hosp Zhengzhou, Liver Transplantat Hepatobiliary Surg Dept, Zhengzhou, Henan, Peoples R China
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2019年 / 515卷 / 04期
关键词：
D O I：
10.1016/j.bbrc.2018.11.198
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：728 / 728
页数：1
相关论文
共 50 条
  • [1] RETRACTED: miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A (Retracted Article)
    Shao, Mingchen
    Geng, Yiwei
    Lu, Peng
    Xi, Ying
    Wei, Sidong
    Wang, Liuxing
    Fan, Qingxia
    Ma, Wang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 464 (04) : 1309 - 1313
  • [2] RETRACTION: Curcumin inhibits growth of Prostate carcinoma via miR-208-mediated CDKN1A activation (Retraction of Vol 36, Pg 8511, 2015)
    Guo, H.
    Xu, Y.
    Fu, Q.
    TUMOR BIOLOGY, 2017,
  • [3] RETRACTION: LncRNA SNHG16 promotes migration and invasion through suppression of CDKN1A in clear cell renal cell carcinoma (Retraction of Vol 24, Pg 3572, 2020)
    Liu, S. -B.
    Wang, H. -F.
    Xie, Q. -P.
    Li, G.
    Zhou, L. -B.
    Hu, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7216 - 7216
  • [4] RETRACTION: Propranolol suppresses HUVEC viability, migration, VEGF expression, and promotes apoptosis by downregulation of miR-4295 (Retraction of Vol 120, Pg 6614, 2019)
    Zhao, Feng
    Yang, Xiaoliang
    Xu, Guangqi
    Bi, Jianhai
    Lv, Renrong
    Huo, Ran
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S135 - S135
  • [5] miR-4295 promotes cell proliferation, migration and invasion of osteosarcoma through targeting interferon regulatory factor 1
    Cheng, Jin Pei
    Huang, Bin
    Duan, Jun Hu
    Yi, Kai Jun
    Zhuang, Zheng Ling
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [6] RETRACTION: miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN (Retraction of Vol 34, Pg 1003, 2015)
    Liu, Kai
    Liu, Songyang
    Zhang, Wei
    Jia, Baoxing
    Tan, Ludong
    Jin, Zhe
    Liu, Yahui
    ONCOLOGY REPORTS, 2022, 47 (02)
  • [7] RETRACTION: miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5 (Retraction of Vol 458, Pg 714, 2015)
    Wang, Yongfang
    Xu, Lianhong
    Jiang, Lixin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (04) : 729 - 729
  • [8] RETRACTION: miR-663 promotes NPC cell proliferation by directly targeting CDKN2A (Retraction of Vol 16, Pg 4863, 2017)
    Liang, Shaoqiang
    Zhang, Ning
    Deng, Yanming
    Chen, Lusi
    Zhang, Yang
    Zheng, Zhenhe
    Luo, Weijun
    Lv, Zhiqian
    Li, Shaoen
    Xu, Tao
    MOLECULAR MEDICINE REPORTS, 2022, 25 (01)
  • [9] RETRACTION: MTA1 promotes proliferation and invasion in human gastric cancer cells (Retraction of Vol 8, Pg 1785, 2015)
    Yao, Y.
    Feng, S.
    Xiao, M.
    ONCOTARGETS AND THERAPY, 2017, 10 : 1519 - 1519
  • [10] RETRACTION: miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN (Retraction of Vol 470, Pg 187, 2016)
    Meng, Xiangrui
    Lu, Peng
    Fan, Qingxia
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (04) : 727 - 727
12345